Public Relations


"Starting with our proprietary positioning and messaging methodology – LHS Immersion® – we partner with clients to develop integrated communications’ programs that build influence and awareness and reach the right stakeholders, with the right messages at the right time."

--Sharon Correia

Our Public Relations services help our clients educate target audiences about their unique value proposition through corporate and product story development. We build influence and awareness to position our clients and/or their products as the right choice for critical stakeholders.
We provide:

Douglas Russell

Senior Vice President & General Manager

Phone: 617-374-8800 x108
Email: drussell@lavoiehealthscience.com

Sharon Correia

Vice President, Integrated Communications

Phone: 617-374-8800 x105
Email: scorreia@lavoiehealthscience.com

Bell Ringer Merit Award 2016

PAIN: a conversation with highly-regarded speakers, digital content, advocacy group outreach, and media relations. The event drew a standing-room crowd, including several leaders and advocacy groups, to a premier Boston hotel for a networking reception and panel.

@LaVoieGroup

- 2 days ago

Are you looking to work with an innovative agency to solve complex communications challenges? Do you want to be on… https://t.co/ZtKPL7Svji
@LaVoieGroup

- 2 days ago

.@dlavoie02 discussing #stateofpossible and the importance of life long learning @YearUpBoston today. Thanks… https://t.co/TRI7oNoyU0
@LaVoieGroup

- 2 days ago

"Since 2011, we've seen over a 50% increase in the number of publicly-traded biotech companies." Nice piece with in… https://t.co/zDRqNyePAa
@LaVoieGroup

- 3 days ago

RT @CheckOrphan: Emmaus, a Leader in #SickleCellDisease Treatment, Signs #Agreement with Cardinal Health to Solidify Distribution Network f…

Example of Public Relations: Panel Development

PAIN: a Conversation brought together industry leaders to participate in a discussion about opioid addition and the need for alternatives. This panel discussion drew nearly 100 clinicians, scientists, patient advocates, patients, investors and biotech/pharma industry professionals.